Transgenomic has named Craig Tuttle as its new CEO. He succeeds Mike Summers, the current interim CEO, who will stay on as CFO.
Biogen Idec announced today that Cecil B. Pickett, Ph.D., has been named president, research & development. Dr. Pickett will join the Biogen Idec board of directors.
Manhattan Pharmaceuticals has named Michael G. McGuinness CFO.
LTKfarma announced its formation and the executive team that will run the company: Alain Clergeot, Tamara Joseph, David Klatzmann, Jean-Francois Labbe, Laurent de Narbonne and Leo van Wersch.
Timothy C. Barabe has joined Human Genome Sciences as senior vice president and chief financial officer.
Angiotech Pharmaceuticals named Jeffrey P. Walker, MD as senior vice president, research and development.
Savient Pharmaceuticals has named Brian Hayden as senior vice president, CFO and treasurer.
Jonathan Burgin has left his position as CFO of XTL Biopharmaceuticals. Bill Kessler, the company's finance director, will become principal financial and accounting officer for financial and compliance reporting purposes.
The Perrigo Company has named Judy Brown executive vice president, CFO and chief accounting officer effective July 1, 2006. She succeeds Douglas Schrank, who retired June 30.
ARCA Discovery has named Ann Lenich Hards, Ph.D., as executive vice president, regulatory affairs.
AtheroGenics has named Joseph M. Gaynor, Jr. senior vice president and general counsel.
Oculus Innovative Sciences has named Michael Wokasch as COO.
Anadys Pharmaceuticals has named James L. Freddo, M.D., as chief medical officer.
Depomed appointed Matthew Gosling as vice president, legal and general counsel.
Gene Network Sciences has appointed Zach Pitluk, Ph.D., as vice president of business development.
SkinMedica announced that Theodore Ebel has joined the company as vice president, corporate development
Alexion has named David Hallal as vice president of US commercial operations.
Metabolix has named Robert C. Findlen as vice president, sales and marketing.
Eisai has appointed Alex Scott as vice president of business development.
Michael Pinto has joined Model N as vice president of sales.
Clinical Data has appointed Robert Bondaryk, Ph.D, to the position of general manager and unit head, Cogenics.
MTM Laboratories has made two new clinical research appointments: Lisa Kaufman is heading clinical operations in the U.S. while Petra Klement is leading clinical operations in Europe.
Lux Biosciences has named David R. Guyer, MD, venture partner, SV Life Sciences Advisers, to its board of directors.
Jim Brown has resigned from the board at Iomai, citing his duties as head of R&D at MedImmune.
INNOVIVE Pharmaceuticals has named Antony Pfaffle, M.D. and J. Jay Lobell to its board.
Pheromone Sciences has appointed Charles Allard, LLB of Edmonton, Alberta, to its board of directors.
Chromos Molecular Systems announced that Ron MacKenzie has been appointed to its board of directors.
PeriCor Therapeutics, has elected Robert L. Engler, M.D. to its board.